EASTGATE BIOTECH CORP
company.status.inactiveCIK 1099574fmd_1Z6FKVPM1QJSGTZQB78BHE0EMRFinance, Insurance and Real Estate · Investors, NECTemplate: Standard
Coverage: Jan 01, 2005 to Sep 30, 2017, 35 periods
| Line item | FY2007 | FY2008 | FY2009 | FY2010 | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cost of revenue | – | – | – | – | – | – | – | – | 0 | – |
| Gross profit | – | – | – | – | – | – | – | – | 0 | – |
| Research and development | – | – | – | – | 0 | 0 | 0 | 1 | 1 | 1 |
| Selling, general and administrative | – | – | – | – | – | – | 1 | 4 | 3 | 2 |
| Total operating expenses | – | – | – | 0 | 0 | 1 | 2 | 5 | 4 | 3 |
| Operating income | – | – | – | – | – | – | (2) | (5) | (4) | (3) |
| Interest expense | – | – | – | (0) | (0) | (0) | 0 | 0 | 0 | 0 |
| Other non-operating income (expense) | – | – | – | – | – | – | (0) | (0) | (0) | (0) |
| Income before taxes | – | – | – | – | – | – | (2) | (5) | (4) | (3) |
| Net income from continuing operations | – | – | – | (0) | (0) | (1) | (2) | – | – | – |
| Net income | (0) | (0) | (0) | (0) | (0) | (1) | (2) | (5) | (4) | (3) |